CytoMed Therapeutics Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
CytoMed Therapeutics has a total shareholder equity of SGD10.2M and total debt of SGD425.7K, which brings its debt-to-equity ratio to 4.2%. Its total assets and total liabilities are SGD10.9M and SGD748.8K respectively.
Belangrijke informatie
4.2%
Verhouding schuld/eigen vermogen
S$425.72k
Schuld
| Rente dekkingsratio | n/a |
| Contant | S$6.82m |
| Aandelen | S$10.16m |
| Totaal verplichtingen | S$748.82k |
| Totaal activa | S$10.91m |
Recente financiële gezondheidsupdates
Geen updates
Recent updates
Analyse van de financiële positie
Kortlopende schulden: GDTC's short term assets (SGD7.7M) exceed its short term liabilities (SGD357.9K).
Langlopende schulden: GDTC's short term assets (SGD7.7M) exceed its long term liabilities (SGD390.9K).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: GDTC has more cash than its total debt.
Schuld verminderen: Insufficient data to determine if GDTC's debt to equity ratio has reduced over the past 5 years.
Balans
Analyse van de cashflow
Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.
Stabiele cash runway: GDTC has sufficient cash runway for more than a year based on its current free cash flow.
Voorspelling contante baan: GDTC has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 24.4% each year.